KLTO
Price:
$0.381
Market Cap:
$8.91M
Klotho Neurosciences, Inc. operates as a biopharmaceutical enterprise focused on devising medical treatments for various conditions, including cancer, cardiovascular ailments, and neurodegenerative disorders. Their leading gene therapy assets encompass AMI-101, which is designed for the management or prevention of Alzheimer's disease, and AMI-202, aimed at treating or averting amyotrophic lateral sclerosis. Formerly known as Anew Medical, Inc., the company underwent a name change to Klotho Neurosciences, Inc. in September 2024. The firm's main office is situated in Omaha, Nebraska.
Industry
Biotechnology
IPO Date
2022-04-29
Stock Exchange
NASDAQ
Ticker
KLTO
According to Klotho Neurosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -135057.00. This represents a change of -100.90% compared to the average of 14.93M of the last 4 quarters.
The mean historical Enterprise Value of Klotho Neurosciences, Inc. over the last ten years is 2.82M. The current -135057.00 Enterprise Value has changed -578.39% with respect to the historical average. Over the past ten years (40 quarters), KLTO's Enterprise Value was at its highest in in the March 2022 quarter at 231.11M. The Enterprise Value was at its lowest in in the June 2025 quarter at -927465.60.
Average
2.82M
Median
3.54M
Minimum
0
Maximum
4.81M
Discovering the peaks and valleys of Klotho Neurosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Enterprise Value = 4.81M
Minimum Annual Increase = -20.66%
Minimum Annual Enterprise Value = 0
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 3.54M | -20.66% |
| 2024 | 4.46M | -7.21% |
| 2023 | 4.81M | 268.16% |
| 2022 | 1.31M | Infinity% |
The current Enterprise Value of Klotho Neurosciences, Inc. (KLTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.27M
5-year avg
2.82M
10-year avg
2.82M
Klotho Neurosciences, Inc.’s Enterprise Value is less than Cadrenal Therapeutics, Inc. Common Stock (1.61M), greater than Rallybio Corporation (-1782699.00), less than Exicure, Inc. (6.89M), less than Minerva Neurosciences, Inc. (136.54M), greater than iBio, Inc. (-34460159.00), less than NeuroSense Therapeutics Ltd. (11.88M), less than Sonnet BioTherapeutics Holdings, Inc. (3.36M), less than TAO Synergies Inc. (28.12M), greater than MetaVia Inc. (-8956698.00), less than NeurAxis, Inc. (87.16M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.61M | $4.00M | |
| -1782699.00 | $91.07M | |
| 6.89M | $8.60M | |
| 136.54M | $161.20M | |
| -34460159.00 | $19.74M | |
| 11.88M | $11.88M | |
| 3.36M | $8.43M | |
| 28.12M | $30.49M | |
| -8956698.00 | $3.50M | |
| 87.16M | $95.20M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Klotho Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Klotho Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Klotho Neurosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Klotho Neurosciences, Inc. (KLTO)?
What is the 3-year average Enterprise Value for Klotho Neurosciences, Inc. (KLTO)?
What is the 5-year average Enterprise Value for Klotho Neurosciences, Inc. (KLTO)?
How does the current Enterprise Value for Klotho Neurosciences, Inc. (KLTO) compare to its historical average?